Spectral Diagnostics Inc. (OTCMKTS:EDTXF – Get Free Report)’s stock price was down 1.7% during trading on Wednesday . The stock traded as low as $0.9241 and last traded at $0.9241. 4,000 shares were traded during trading, a decline of 58% from the average daily volume of 9,423 shares. The stock had previously closed at $0.94.
Spectral Diagnostics Price Performance
The company has a market capitalization of $265.92 million, a P/E ratio of -9.05 and a beta of 0.16. The company has a 50 day moving average of $0.97 and a 200-day moving average of $0.99.
About Spectral Diagnostics
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.
Featured Articles
- Five stocks we like better than Spectral Diagnostics
- Accelerant’s Take-Private Deal Raises a Bigger Question for Insurance Stocks
- 3 CEOs Are Buying Millions of Dollars of Their Beaten-Down Stocks
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
Receive News & Ratings for Spectral Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
